Capital expenditure · 2023–2025

Caris Life Sciences capital expenditure

$16.3M+92.6% · FY2025

Caris Life Sciences (CAI) reported $16.3M in capital expenditure for fiscal 2025, +92.6% year on year.

$22.3M2023$8.4M2024$16.3M2025
Caris Life Sciences — Capital expenditure, 2023–2025
Fiscal yearCapital expenditureChangeFiling
FY20252025-12-31$16.3M+92.6%Open →
FY20242024-12-31$8.4M−62.2%Open →
FY20232023-12-31$22.3M—Open →

Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2023–2025 compound annual growth −14.6%

Capital expenditure at companies of similar size

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Caris Life Sciences capital expenditure |url=https://companiesranked.com/en/company/caris-life-sciences/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Caris Life Sciences capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/caris-life-sciences/capital-expenditure

BibTeX

@misc{companiesranked-en-company-caris-life-sciences-capital-expenditure-2026,
  author       = {{CompaniesRanked}},
  title        = {{Caris Life Sciences capital expenditure}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/caris-life-sciences/capital-expenditure}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-K · 0002019410-26-000016 · March 3, 2026

{{cite web |title=Caris Life Sciences capital expenditure — 10-K (0002019410-26-000016) |url=https://www.sec.gov/Archives/edgar/data/2019410/000201941026000016/cai-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-03}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Caris Life Sciences overview